Genus (GNS) Trading update summary
Event summary combining transcript, slides, and related documents.
Trading update summary
16 Jan, 2026Financial performance
Adjusted profit before tax for H1 FY26 expected at approximately £50m, ahead of expectations.
Including a milestone payment, adjusted profit before tax rises to about £55.6m.
FY26 adjusted profit before tax now forecast moderately above the top end of current market expectations.
Strategic developments
Regulatory approval received for the Chinese porcine joint venture in December 2025.
Final $7.5m (£5.6m) milestone payment from BCA triggered by joint venture approval.
Joint venture formation and milestone payment expected in fiscal Q3.
Operational highlights
Strong trading continued in PIC, with ABS performing as anticipated.
Interim results for H1 FY26 will be announced on 26 February 2026.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Genus
- Record profit, strong PIC and ABS growth, and major China JV drive positive FY26 outlook.GNS
H1 202626 Feb 2026 - Profit growth expected in FY25 after strategic gains and cost savings, despite market challenges.GNS
H2 202422 Jan 2026 - Profit fell as China and ABS faced headwinds, but margin and PRP progress continued.GNS
H2 2024 (Q&A)22 Jan 2026 - Market leadership, innovation in gene editing, and China expansion drive strong growth prospects.GNS
44th Annual J.P. Morgan Healthcare Conference Presentation16 Jan 2026 - Profit outlook raised to top end of expectations as both ABS and PIC segments outperform.GNS
Trading Update7 Jan 2026 - Strong H1 profit growth, margin gains, and strategic progress drive a positive outlook.GNS
H1 202529 Dec 2025 - Record profit growth, China JV acceleration, and FDA PRP approval drive strong FY25 results.GNS
H2 20254 Sep 2025 - Strong trading, milestone receipts, and robust cash flow drive FY25 profit in line with guidance.GNS
Trading Update17 Jul 2025 - Strong trading and strategic progress position Genus for significant profit growth in FY25.GNS
Trading Update13 Jun 2025